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 CD4 + T helper cells represent a diverse 
and ever-expanding assortment of im-
mune cells, including Th1, Th2, Th3, 
Th17, and T regulatory (T reg) cells. 
The last three subsets are relatively new 
arrivals on the scene, whereas Th1 and 
Th2 cells have been the focus of in-
tense research since their original defi -
nition by Mosmann et al. in the late 
1980s ( 1 ). Most facets of the CD4 + T 
cell response  including induction, de-
velopment, maintenance, eff ector func-
tion, and memory function  are better 
understood in Th1 cells than in their 
Th2 counterparts. This can be ex-
plained in part by the fact that Th1 cells 
drive the pathology of many of the 
most severe and debilitating diseases 
that aff ect the developed world. How-
ever, Th2 responses are also important, 
and not simply because of their ability 
to counterregulate Th1 development. 
Th2 responses can be benefi cial, for 
example, in protection against helminths. 
But this type of response may also be 
severely damaging, such as in fi brotic 
or allergic disease. It is widely recog-
nized that without a detailed under-
standing of the specifi c pathways of 
diff erential T helper cell development 
we cannot determine how best to cor-
rect dysregulated immune responses. 
 DCs are pivotal in the control of de-
veloping immune responses, as they 
govern both the initiation and polariza-
tion of adaptive immunity ( 2 ). Although 
Th1 induction by DCs is relatively well 
documented and rapid progress is being 
made on Th17 stimulation ( 3 ), there is a 
glaring defi ciency in our understanding 
of the mechanisms used by DCs to induce 
and direct Th2 responses. Emerging ev-
idence, particularly from studies on DC 
responses to helminths (the Th2 experts), 
suggests that DCs stimulated in Th2 en-
vironments tend to fl aunt conventional 
defi nitions of DC activation. Moreover, 
Th2-inducing DCs are generated not 
only in infection but also by exposure to 
innocuous allergens ( 4 ) and, most sur-
prisingly, to endogenous ligands such as 
the cytokine thymic stromal lymphopoi-
etin (TSLP) ( 5 ). In the latter context, a 
new study from Yang et al. on page 79 
of this issue ( 6 ) suggests that innate cells 
can shape adaptive immunity through the 
release of the antimicrobial protein eo-
sinophil-derived neurotoxin (EDN), a 
ribonuclease with antiviral properties 
that can also act as a chemoattractant and 
activation stimulus for DCs ( 7 ). 
 DC instruction of Th cell 
differentiation 
 The current paradigm of DC-driven 
activation of naive Th cells draws heav-
ily on events that occur after the stimu-
lation of resting DCs with strong ligands 
of the innate Toll-like receptors (TLRs), 
such as lipopolysaccharide, CpG, and 
others ( 8 ). Binding of these molecules 
to their receptors initiates signaling cas-
cades, primarily through the adaptor 
MyD88, resulting in stable presentation 
of major histocompatibility complex II –
 peptide complexes to T cells (signal 1), 
and up-regulation of the co-stimulatory 
molecules CD40, CD80, and CD86 
(signal 2). In the generation of a Th1 
response, DCs subsequently release 
interleukin (IL) 12, which can be con-
sidered signal 3 (a qualitative signal that 
directs T cell polarization) ( 9 ). Similarly, 
Th17 may be promoted by DC-derived 
IL-1, IL-6, or IL-23 ( 3 ). For Th2 in-
duction, we know that DCs must like-
wise express major histocompatibility 
complex II ( 10 ), CD40 ( 11 ), CD80, 
and CD86 ( 12 ). However, the Th2-
specifi c drivers, whether DC receptor/
ligand pairs and/or a signal 3 counter-
part for Th2 cells, have not been identi-
fi ed. In terms of cytokines, IL-4 and 
IL-10 are both attractive candidates for 
a Th2-driving signal 3 from DCs, but 
both IL-4 – ( 13, 14 ) and IL-10 – defi -
cient ( 15 ) DCs can still drive Th2 re-
sponses. Indeed, DC-produced IL-10 
may be more important for the genera-
tion of regulatory environments ( 16 ) 
and/or in delaying DC apoptosis in the 
face of overt stimulation ( 17 ) than in 
directing Th2 development. 
 Our ignorance of Th2-associated 
DC signals has led to the view that the 
mere absence of IL-12 leads, by default, 
to a Th2 outcome. Although this can 
occur when T cell receptor – transgenic 
T cells are stimulated in vitro in the ab-
sence of IL-12, this explanation is diffi  -
cult to apply to more complex in vivo 
events, as discussed below. Furthermore, 
in settings where Th2 responses are 
critical for pathogen clearance or pre-
vention of excess immunopathology, 
reliance on a default process seems 
unlikely. In this context, the recent im-
plication of the co-stimulatory tumor 
necrosis factor superfamily member 
OX-40L ( 9, 18, 19 ) and the Notch li-
gands jagged1 and jagged2 ( 20 ) in the 
generation of Th2 responses carries 
There is an ever-increasing understanding of the mechanisms by which 
pathogens such as bacteria, viruses, and protozoa activate dendritic cells (DCs) 
to drive T helper type 1 (Th1) responses, but we know much less about how 
these cells elicit Th2 responses. This gap in our knowledge puts us at a dis-
tinct disadvantage in designing therapeutics for certain immune-mediated 
diseases. However, progress is being made with the identifi cation of novel 
endogenous tissue factors that can enhance Th2 induction by DCs.
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can occur even in the presence of TLR-
dependent signals that are capable of 
driving complete DC maturation and 
normally induce a Th1 response. 
 It seems likely that DC activation 
has more dimensions than we currently 
appreciate, and the very plasticity of 
DC function may require a spectrum of 
distinct activation states to induce each 
of the diff erent T cell outcomes ( 8 ). 
What is clear at this stage is that the ac-
tivation phenotype of DCs, as currently 
measured after stimulation, does not 
always faithfully predict their ability to 
infl uence T cell polarization. Absence 
of overt DC activation can drive a Th2 
response or tolerance induction, and 
production of IL-12 by DCs does not 
always guarantee a Th1 response.
production and surface activation marker 
expression. This muted phenotype is 
reminiscent of some descriptions of 
tolerogenic DCs ( 22 ), yet these cells are 
still potently immunogenic and are capa-
ble of polarizing Th2 responses both 
in vitro and in vivo ( 10, 12, 14, 18, 23, 24 ). 
These observations appear to support 
the idea that Th2 development occurs 
by default when DCs are activated above 
their tolerogenic resting state in the ab-
sence of TLR ligands. ( Fig. 1 A ). How-
ever, NES was found to induce a Th2 
response even when coadministered with 
potent TLR stimuli in complete Freund ’ s 
adjuvant ( 25 ). When DCs were coex-
posed to SEA and bacterial antigen, they 
continued to induce an SEA-specifi c Th2 
response ( 26 ). Hence, a Th2 outcome 
both mechanistic and polemical signifi -
cance. Further unraveling of the rela-
tive importance of these molecules, and 
others that will undoubtedly be revealed 
in due course, is eagerly awaited. 
 Th2 induction in the absence of overt 
DC activation? 
 The range of candidate molecules that 
DCs must express to effi  ciently provoke 
Th2 responses is increasing. However, 
an intriguing hallmark of DC activation 
by Th2-type antigens, such as  Schistosoma 
mansoni soluble egg antigen (SEA) ( 21 ), 
excretory/secretory material from  Nip-
postrongylus brasiliensis (NES) ( 18 ), or 
 Acanthocheilonema viteae ( 12 ), is that the 
DCs fail to display the conventional suite 
of stimulation events, such as cytokine 
 Figure 1.  Alternative models for selective Th1/Th2 induction by DCs. (A) The maturation model, which posits that Th1 stimuli drive immature DCs 
(iDC) to develop into completely mature DCs (mDC) able to induce Th1 via signal 3 (e.g., IL-12) provision to T cells. In contrast, most Th2 stimuli elicit little 
or no activation, generating semimature DCs (sDC), which fail to provide signal 3. In the absence of complete DC maturation, responses default to the Th2 
mode. Because EDN activates DCs (and their secretion of IL-12) while promoting Th2 induction, it does not fi t into this scheme. (B) The alternate pathway 
model, in which Th1 and Th2 stimuli are linked to distinct sets of pattern recognition receptors (PRR), such as TLRs and CLRs. For example, strong signal-
ing through TLRs initiates intracellular cascades, principally involving MyD88, which up-regulate proinfl ammatory cytokine production, including that of 
IL-12. In contrast, ligation with a CLR-binding, Th2-inducing stimulus can activate Syk in a pathway that favors IL-10 rather than IL-12, although no con-
sequent signal 3 has been identifi ed (reference  31 ). The outcome of exposure to complex antigens may depend on the relative strength of signal in two or 
more competing receptor-dependent pathways. (C) The inhibition model, in which signaling pathways may intersect and inhibit one another. For example, 
Th2 stimuli that up-regulate ERK phosphorylation and stabilize c-Fos effect an intracellular block on IL-12 production (reference  23 ). In a complementary 
fashion, strong TLR4 ligation can negate the ability of SEA to induce Th2 responses, though in this instance the signaling mechanism has yet to be de-
fi ned (reference  32 ). The default model is unlikely to hold true in most in vivo Th2 settings, whereas a combination of the alternate pathway and inhibi-
tion models is perfectly plausible. 
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 Can CLR signaling infl uence Th 
cell subset instruction? The   -glucan re-
ceptor dectin-1 (CD37) may act in this 
capacity. Dectin-1 signals via Card9 ( 31 ) 
and Src/Syk ( 32 ), and Syk   /   DCs me-
diate a more IL-12 – dominated response. 
Thus, a plausible scenario is that MyD88-
dependent, pro-Th1 signals compete 
with pro-Th2 signals mediated through 
molecules such as Syk ( Fig. 1 B ). Inter-
estingly, the dectin-1 and TLR2 path-
ways synergize ( 32 ), indicating that 
competition or positive reinforcement 
can occur in diff erent settings. 
 Th1 versus Th2: competition 
or inhibition? 
 If Th1 and Th2 ligands initiate distinct, 
but intersecting, signal cascades, is their 
interplay simply competitive or is there 
cross-inhibition at the molecular level 
( Fig. 1 C )? Negative signaling might 
well account for the ability of Th2 lig-
ands to suppress DC-driven induction of 
Th1 responses ( 14, 27 ). The most prom-
inent example of interference with Th1 
induction by Th2-driving molecules is 
the blocking of IL-12 production (either 
or both p40 and p70) in DCs pretreated 
with NES or SEA before LPS challenge 
( 14, 18, 26 ). Th1-inducing agents can, 
in turn, block Th2 outcomes. In this 
of the transcription factor c-Fos ( 24, 27 ), 
schistosome sugars can act via TLR4 to 
condition Th2-driving DCs ( 28 ), and 
schistosome lipids bind TLR2 to induce 
IL-10 – producing Tr1 cells ( 23 ). The 
triggering of TLR2/MyD88 by EDN 
shown by Yang et al. ( 6 ) is therefore con-
sistent with these other reports of Th2-
associated DC stimuli. But conclusive 
evidence that TLRs or MyD88 have a 
fundamental role in directing DCs to in-
duce Th2 responses is lacking. And be-
cause DC-driven Th2 induction can 
occur in an MyD88-independent fashion 
( 14 ), it may be that Th2 responsiveness is 
not as dependent on the MyD88 path-
way as is Th1. 
 Recently, C-type lectin receptors 
(CLRs) have drawn attention both as 
markers of DC subsets and as initiators 
of key signaling events within the DCs 
( 29 ). Information about the range of 
CLRs bound by Th2-skewing patho-
gens is currently limited. But schisto-
some components have been shown to 
interact with a variety of CLRs expressed 
by DCs, including DC-SIGN, macro-
phage-galactose type lectin, and the 
mannose receptor, and this may aff ect 
internalization of the antigen and the 
shifting capacity of the DCs to polarize 
T cells ( 30 ). 
As Yang et al. now show, EDN pro-
vides another example of this separation 
between the DC activation profi le and 
the kind of Th response with which it is 
aligned in that it appears to activate DCs 
similarly to many Th1 antigens and, yet, 
has Th2-inducing adjuvant properties ( 6 ). 
Human monocyte-derived DCs exposed 
to recombinant EDN in vitro up-regu-
lated surface activation markers, secreted 
cytokine, and displayed an altered migra-
tion capacity and an increased ability to 
provoke allogeneic T cell proliferation, a 
profi le typical of conventionally activated 
DCs. Nevertheless, injection of mice with 
EDN, or transfer of ovalbumin/EDN-
pulsed DCs, generated Th2 rather than 
Th1 immunity, suggesting that a muted 
activation phenotype will not always be 
a prerequisite for Th2 induction by 
DCs ( 6 ). 
 How are Th2 antigens recognized 
by DCs? 
 So far we have very little knowledge 
of which pathogen-derived molecules 
bind to which receptors on DCs to con-
fer Th2-inductive capacity. TLRs and 
MyD88 have been implicated in this pro-
cess: ligation of TLR2 can induce a Th2 
response via extracellular signal-regulated 
kinase phosphorylation and stabilization 
 Figure 2.  Exogenous and endogenous Th2-inducing stimuli acting through DCs. Th2 stimuli include both exogenous and endogenous ligands. 
Examples from parasites include SEA (reference  9 ), NES (reference  17 ), and  Acanthocheilonema viteae excretory secretory 62-kD antigen (ES62; reference 
 11 ), which directly drive Th2 induction through DCs. Proteases released from parasites or contained within allergenic material may activate endogenous 
substrates to initiate the Th2 pathway. Endogenous tissue factors that promote Th2 include TSLP and EDN, as well as prostaglandins D and E, which may 
also be produced or induced by parasitic helminths (green dashed arrow). It is not known if endogenous tissue factors may also act directly on developing 
T cells to infl uence subset choice, but two key cytokines (transforming growth factor   and IL-6) are included for their role in T reg and Th17 induction. 
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will DCs retain their preeminence or 
will other antigen-presenting cells (such 
as B cells) supercede them? 
 Conclusion 
 We can now conclude that both Th1 
and Th2 stimulations are active pro-
cesses, albeit using diff erent suites of sig-
nals. Perhaps the true default pathway is 
homeostatic maintenance of tolerance 
by resting DCs unruffl  ed by tissue fac-
tors, alarmins, or foreign molecules. The 
actual mechanism of Th2 induction via 
DCs, whether in response to exogenous 
(e.g., helminth) or endogenous (e.g., 
EDN) ligands, is still poorly understood. 
At this point, we cannot be sure that 
there is a single mechanism or whether a 
combination of passive (default), active 
(induction), and competitive pathways 
are at play. EDN is a new and important 
character in the roll call of Th2-promot-
ing factors, illustrating the intimacy and 
complexity of communication between 
host tissues and the decision-making 
machinery of the immune system. 
 The laboratories of A.S. MacDonald and R. Maizels 
are supported by the Wellcome Trust and the Medical 
Research Council. 
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